<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-QSB
[x] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
FOR THE QUARTERLY PERIOD ENDED JULY 31, 1998
OR
[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
For the transition period from _____________ to _______________
COMMISSION FILE NUMBER 0-15673
INTERNATIONAL ABSORBENTS INC.
(Exact name of registrant as specified in its charter)
Province of British Columbia, Canada None
(State of other jurisdiction of (IRS Employer
incorporation or organization) Identification Number)
300 - 1055 West Hastings Street
Vancouver, British Columbia
Canada V6E 2E9
(Address of principal executive offices)
(604) 681-6181
(Registrant's telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the Registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.
Yes [x] No [ ]
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of August 31, 1998.
<TABLE>
<CAPTION>
Title of Class No. of Shares
<S> <C>
Common Shares, no par value 19,601,052
</TABLE>
Page 1 of 6
<PAGE> 2
INTERNATIONAL ABSORBENTS INC.
CONSOLIDATED BALANCE SHEETS
(US dollars, in thousands)
<TABLE>
<CAPTION>
JULY 31, 1998 JANUARY 31, 1998
<S> <C> <C>
ASSETS
Current assets:
Cash $ 64 $ 46
Accounts receivable 571 617
Inventories 351 355
Prepaid expenses 71 72
-------------------------
$ 1,057 $ 1,090
Fixed assets 1,027 1,024
Other assets 73 77
-------------------------
$ 2,157 $ 2,191
=========================
LIABILITIES
Current liabilities:
Accounts payable $ 753 $ 740
Operating line of credit 379 504
Convertible debentures 0 250
Due to related parties (Note 2) 24 44
-------------------------
$ 1,156 $ 1,538
SHAREHOLDERS' EQUITY
Share capital (Note 3) $ 6,583 $ 6,332
Deficit (5,582) (5,679)
-------------------------
$ 2,157 $ 2,191
=========================
</TABLE>
INTERNATIONAL ABSORBENTS INC.
CONSOLIDATED STATEMENT OF OPERATIONS
(US dollars, in thousands)
<TABLE>
<CAPTION>
6 MONTHS 6 MONTHS 3 MONTHS 3 MONTHS
7/31/98 7/31/97 7/31/98 7/31/97
<S> <C> <C> <C> <C>
Sales revenues $ 2,840 $ 2,498 1,429 $ 1,381
Cost of goods sold 1,845 1,704 919 897
--------------------------------------------------------------------
995 794 510 484
Gross margin 35% 32% 36% 35%
Corporate and administrative expenses:
Marketing and sales 411 413 216 237
General and administrative 496 704 235 359
--------------------------------------------------------------------
907 1,117 451 596
Profit/(loss) before undernoted item 88 (323) 59 (112)
Other income 9 5 1 3
--------------------------------------------------------------------
Profit/(loss) for the period 97 (318) 60 (109)
====================================================================
Deficit at beginning of period (5,679) (5,086) (5,642) (5,295)
Deficit at end of period (5,582) (5,404) (5,582) (5,404)
====================================================================
EBIDT 204 (195) 130 (43)
Profit/(loss) per common share (in dollars) 0.01 (0.02) 0.00 (0.01)
====================================================================
Weighted average number of common shares (in
thousands) 18,279 14,996 19,601 15,041
====================================================================
</TABLE>
Page 2 of 6
<PAGE> 3
INTERNATIONAL ABSORBENTS INC.
CONSOLIDATED STATEMENTS OF CHANGES IN FINANCIAL POSITION
(US dollars, in thousands)
<TABLE>
<CAPTION>
6 MONTHS ENDED
JULY 31, 1998 JULY 31, 1997
<S> <C> <C>
Cash flows from operating activities 74 (59)
Cash flows used in investing activities (57) (18)
Cash flows used in financing activities 1 31
Net change in cash 18 (46)
-----------------------
Cash and cash equivalents, beginning of period 46 97
-----------------------
Cash and cash equivalents, end of period 64 51
=======================
</TABLE>
NOTES TO CONSOLIDATED FINANCIAL STATEMENT
(US dollars except where otherwise noted)
1. BASIS OF CONSOLIDATION AND PRESENTATION
The consolidated financial statements include the accounts of International
Absorbents Inc. ("IABS") and its wholly-owned subsidiaries Absorption Corp
("Absorption"), a Nevada company doing business in Washington State, and Total
Absorb Inc. ("TAI"), a British Columbia company.
The accompanying consolidated financial statements have been prepared in
accordance with accounting principles generally accepted in Canada and with the
instructions to form 10-Q and Rule 10 of Regulation S-X promulgated by the
United States Securities and Exchange Commission. Differences with respect to
accounting principles generally accepted in the United States, which are not
significant, are disclosed in Note 12. Such financial statements do not include
all disclosures required by generally accepted accounting principles for annual
financial statement reporting purposes. However, there has been no material
change in the information disclosed in the Company's annual consolidated
financial statements dated January 31, 1998, except as disclosed herein.
Accordingly, the information contained herein should be read in conjunction with
such annual consolidated financial statements and related disclosures. Certain
amounts have been restated to conform with the presentation for Fiscal Year
1998.
The accompanying interim consolidated statements reflect, in the opinion of
management, all adjustments (consisting of normal recurring adjustments)
necessary for a fair presentation of the results of the interim periods
presented. Results of operations for the period ended July 31, 1998 are not
necessarily indicative of results expected for an entire year.
Page 3 of 6
<PAGE> 4
MANAGEMENT'S DISCUSSION AND ANALYSIS
Statements made in the following management's discussion and analysis, that
state the company's or management's intentions, hopes, beliefs, expectation or
predictions of the future, are forward-looking statements. It is important to
note that the company's actual results could differ materially from those
projected in such forward-looking statements. Additional information concerning
factors that could cause actual results to differ materially from those in the
forward-looking statements is contained from time to time in the company's SEC
filings, including but not limited to the company's report on forms 10-K, 10-QSB
and the company's proxy statement to shareholders. Copies of these filings may
be obtained by contacting the company or the SEC.
OUTLOOK
Additional sales revenue growth is anticipated through the rest of the current
fiscal year as the Animal Care Division adds staff and continues to expand its
distribution network. Recently having undergone a reorganization, the Industrial
Division is anticipated to continue its business expansion and to gain sales
revenue both internationally and domestically. Expenses are expected to continue
near current levels while sales revenues grow. The net effect will be a positive
income.
SALES REVENUE for the three months ended July 31, 1998 net of allowances and
discounts, were $1,429,000, an increase of 3% in comparison to the three months
ended July 31, 1997 total of $1,381,000. Sales revenue for the six months ended
July 31, 1998, net of allowances and discounts, were $2,840,000, an increase of
14% in comparison to the six months ended July 31, 1997 total of $2,498,000.
This increase in sales revenue was mainly due to an increase in Animal Care
products sales volumes.
For the balance of fiscal year 1999, further sales revenue growth is expected
due to continued expansion of the company's Animal Care distribution, in both
the pet bedding market and the low cost large animal bedding market. This sales
growth will result from the addition of new regional distributors, direct sales
to national accounts, and an increase in volume through existing customers. The
company's Industrial Division is also expected to experience growth as the
division's new marketing strategy takes effect and its repositioned products
gain acceptance.
GROSS PROFIT on total sales for the three months ended July 31, 1998 were
$510,000 (or 36%) versus $484,000 (or 35%) for the three months ended July 31,
1997. Gross profits on total sales for the six months ended July 31, 1998 were
$999,000 (or 35%) versus $794,000 (or 32%) for the six months ended July 31,
1997.
These increases were due to improvements in the company's manufacturing
efficiencies and an increase in price of the company's Animal Care products.
NET PROFIT AND EBIDT improved for the three month period ended July 31, 1998
versus the three month period ended July 31, 1997. Net profits increased to
$60,000 profit, from a loss of $109,000. The company's EBIDT increased from a
loss of $43,000 to a profit of $130,000 for the period. The company's net profit
and EBIDT improved for the six month period ended July 31, 1998 versus the six
month period ended July 31, 1997. Net profit increased to $97,000 profit, from a
loss of $318,000 for the period, a net improvement of $415,000. The company's
EBIDT increased from a loss of $195,000 to a profit of $204,000, a net
improvement of $399,000. These increases are due to an increase in sales, an
improvement in the gross margin and a reduction of general and administrative
costs.
GENERAL AND ADMINISTRATIVE EXPENSES decreased for the three months ended July
31, 1998 to $235,000 from $359,000 for the three months ended July 31, 1997,
resulting in a 35% improvement. These expenses decreased for the six month
period ended July 31, 1998 to $496,000 from $704,000 for the six month period
ended July 31, 1997, resulting in a 30% improvement. These decreases were
principally due to a decrease in administrative staff and the implementation of
new cost controls.
Total general and administrative expenses for the fiscal year are expected to
remain at current levels, but decrease as a percentage of sales.
Page 4 of 6
<PAGE> 5
MARKETING EXPENSES were $216,000 for the three months ended July 31, 1998, a
decrease of 9% from the three month period ended July 31, 1997 total of
$237,000. Marketing expenses were $411,000 for the six months ended July 31,
1998, a decrease of 1% from the six month period ended July 31, 1997 total of
$414,000. This decrease reflects a reduction in Industrial sales and marketing
expenses associated with the Division's restructuring.
Marketing expenses are expected to continue near this level for the remainder of
the 1999 fiscal year, while decreasing significantly as a percentage of sales
revenue.
LIQUIDITY AND CAPITAL RESOURCES
At July 31, 1998 the company had a negative $99,000 in working capital. This was
an improvement from a negative $448,000 at January 31, 1998. The current ratio
(current assets to current liabilities) at period end increased to 0.91 from
0.71 at January 31, 1998. These changes were mainly due to the retirement of
convertible debentures.
CASH FLOW
Cash flow from operations increase to positive $74,000 for the six months ended
July 31, 1998 versus a negative $59,000 for the six months ended July 31, 1997.
PART II - OTHER INFORMATION
4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
At the Annual General Meeting of Shareholders held on July 24, 1998, the
following proposals were adopted by the margins indicated:
1. The selection of Price Waterhouse Coopers to continue as the
auditors for Absorption Corp. was approved by the following vote: For
- 14,362,245; Against - 3,860; Not Voted - 129,150; Spoiled - 65,034.
2. The election of the following directors who will service until
their successors are elected and qualified for two year terms, or
their earlier death or resignation:
<TABLE>
<CAPTION>
NUMBER OF SHARES
FOR NOT VOTED
--- ---------
<S> <C> <C>
Gordon L. Ellis 14,200,244 395,445
Douglas Ellis 14,222,419 337,870
Shawn Dooley 14,267,094 293,195
</TABLE>
3. The adoption of the amendment to the Absorption Corp. Equity
Incentive Option Plan to provide for the continuation of the
automatic annual grant to non-employee director was approved by the
following vote: For - 13,782,321; Against - 1,133,816; Spoiled -
144,150.
4. The repricing of the Absorption Corp. Equity Incentive Option Plan
for options held by insiders of the company from exercise prices
ranging from $0.50 to $1.69 per share to an exercise price of $0.20
per share was approved by the following vote: For - 2,646,602;
Against - 1,133,816; Spoiled - 10,066,978.
Page 5 of 6
<PAGE> 6
5. OTHER INFORMATION
Directors as at July 31, 1998:
Gordon L. Ellis
Stephen H. Silbernagel
John J. Sutherland, Jr.
Douglas Ellis
Shawn Dooley
6. EXHIBITS AND REPORTS ON FORM 8-K
No exhibits
No reports on Form 8-K have been filed during the period ended
July 31, 1998.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
INTERNATIONAL ABSORBENTS INC.
(Registrant)
Date: 9/3/98 /s/ Gordon L. Ellis
----------------------------------------
Gordon L. Ellis
President & CEO
Page 6 of 6
